Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding ...
(PR-inside.com) Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by 2034, up from $1.82 billion in 2025, according to DataIntelo Commercial rollout supported by Nora Pharma's…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Senzime Secures Additional Major US Hospital Network Contract, Expanding ...
- CEO Litz Van Dyke Reflects on 10 Years with Carter Bank
- Qoder Introduces Projects and Discussion to Help Teams Work Together ...
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →